Anthrax Vaccine Market is Projected to Reach USD 9.13 billion by 2030, Driven by Rising Bioterrorism Threats and Military Applications

Mordor Intelligence has published a new report on anthrax vaccine market" offering a comprehensive analysis of trends, growth drivers, and future projection-Mordor intelligence

Introduction:

The anthrax vaccine market is valued at USD 5.98 billion in 2025 and is forecast to reach USD 9.13 billion by 2030, advancing at a 7.30% CAGR. The anthrax vaccine market has gained substantial traction over recent years due to the increasing need for disease prevention against anthrax, a serious infectious disease caused by Bacillus anthracis. The vaccine, which is primarily used for military personnel, healthcare workers, and those in close contact with animals at risk, is integral in combating bioterrorism threats. With growing global concerns over biological warfare and the need for rapid preparedness, the anthrax vaccine market is expected to witness steady growth.

The demand for anthrax vaccines has escalated due to a combination of bioterrorism risks, outbreaks in livestock, and regulatory initiatives in high-risk regions. The market is evolving as public and private sectors collaborate to enhance vaccine availability and deployment. This press release delves into the market's key drivers, trends, segmentation, and the competitive landscape, forecasting continued demand through 2030.

Report Overview: https://www.mordorintelligence.com/industry-reports/anthra-vaccine-market?utm_source=openpr

Key Trends

The anthrax vaccine market is influenced by several key trends that contribute to its growth and development:

Bioterrorism Preparedness: The rise in concerns over bioterrorism continues to be one of the most significant drivers for anthrax vaccine development. Nations, especially those with high-risk profiles, are investing in vaccine stockpiles and preventive measures for their populations and military personnel.

Outbreaks in Livestock: Anthrax is a zoonotic disease, meaning it can transfer from animals to humans. In areas with frequent outbreaks in livestock, the demand for vaccination programs aimed at both animals and humans has intensified, further fueling market growth.

Government Support and Funding: Governments worldwide, particularly in the U.S. and Europe, have initiated funding and research projects for the development of enhanced anthrax vaccines. This has encouraged both public health organizations and private companies to invest more heavily in vaccine development.

Advances in Vaccine Technology: Ongoing research into improving the safety and efficacy of anthrax vaccines continues to shape market trends. New developments aim to reduce side effects and enhance the overall protection offered by these vaccines.

Military and Defense Application: The anthrax vaccine remains a crucial component of military defense strategies. As more countries increase their focus on national security, the military's role in maintaining adequate vaccine supplies continues to grow.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:

https://www.mordorintelligence.com/ja/industry-reports/anthra-vaccine-market?utm_source=openpr

Market Segmentation:

The anthrax vaccine market can be segmented based on various factors, including application, distribution channels, and region:

By Vaccine Type (Value)

Cell-free Anthrax Vaccine Adsorbed (AVA)

Adjuvanted Anthrax Vaccine (AV7909/CYFENDUS)

Recombinant Protective Antigen Vaccine

Others

By End User (Value)

Military & Defense

Government Civilian Agencies

Healthcare Workers & First Responders

Veterinary Sector

General Population High-risk Travelers

By Application (Value)

Pre-Exposure Prophylaxis

Post-Exposure Prophylaxis

By Distribution Channel (Value)

Direct Government Procurement

Hospital & Clinic Pharmacies

Direct Order Suppliers

By Geography

North America

Europe

South America

Middle east&Africa

Asia pacific



Key Players

The global anthrax vaccine market is characterized by the presence of several key players who lead in vaccine production, distribution, and research:

Colondo Serum Company

Merck Co, Inc. (MSD Animal Health)

Emergent BioSolutions Inc.

Proton Biopharma Ltd

Altimmune (Pharmathene Inc.)

Explore more insights on anthrax vaccine market competitive landscape: https://www.mordorintelligence.com/industry-reports/anthra-vaccine-market/companies?utm_source=openpr

Conclusion:

The anthrax vaccine market is set for continued growth, supported by increasing awareness of bioterrorism risks, government funding for vaccine stockpiles, and outbreaks in livestock. Although the market is largely driven by military and defense applications, the rising focus on veterinary use and public health initiatives will ensure broader market opportunities. As new advancements in vaccine technology emerge, the market is poised for further development, with major players focusing on enhancing vaccine efficacy and expanding their geographical presence.

The global anthrax vaccine market's outlook remains strong, and the growing awareness of biological threats will continue to drive the demand for vaccination programs. As we move toward the next decade, the role of anthrax vaccines in both human and animal health will remain a crucial element of global security and disease prevention strategies.

For complete market analysis, please visit the Mordor Intelligence page: https://www.mordorintelligence.com/industry-reports/anthra-vaccine-market?utm_source=openpr

Related Reports

Anthrax Treatment Market: The Anthrax Treatment Market Report Segments the Industry Into by Product Type (Antibiotics, Antitoxinx and More), Rouet of Administration (Oral, Injectabales and More), by End User (Military & Defense Personnel, Civilian Emergency Stockpiles and More), by Distribution Channel (Government Procurement Agencies, Hospitals and More) and Geography (North America, Europe, Asia Pacific and More).

Get More Insights: https://www.mordorintelligence.com/industry-reports/anthrax-treatment-market?utm_source=openpr

Biodefense Market: The Biodefense Market Report is Segmented by Product (Anthrax, Botulism, Smallpox, Nuclear, and Other Products) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Get More Insights: https://www.mordorintelligence.com/industry-reports/biodefense-market?utm_source=openpr

Plant-Based Vaccines Market: The Plant-Based Vaccines Market is Segmented by Vaccine Type (Bacterial Vaccine, Viral Vaccine and Others), Plant Source (Tobacco, Potato, and Others), Application (Human Infectious Disease, Oncology, and Veterinary Applications), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Get More Insights: https://www.mordorintelligence.com/industry-reports/plant-based-vaccines-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.